MAY 21, 2019 10:17 PM PDT

A New Class Of Depression Medication

WRITTEN BY: Abbie Arce

The National Institutes of Health (NIH) estimate that over 17 million adults in the US have had at least one major depressive episode. At any given time, another 24.4 million adults suffer from Post-Traumatic Stress Disorder (PTSD). 

All of the drug therapies available for depression today focus on suppressing the symptoms of the disorder. In the US, even with the highest percentage of the population on antidepressants than anywhere else in the world, the effectiveness of these medications is often scrutinized.

What if instead of suppressing the symptoms, we could develop a medication to help people deal with the stressful situations that cause depression and PTSD before they develop. 

In 2014, neuroscientist Rebecca Brachman and her team may have stumbled upon a drug that does just that. This newly discovered class of drugs works by increasing a person's stress resilience. The idea is that these drugs would boost a person's ability to handle extreme stressors much in the way that a vitamin might raise a person's immune response. 

In the above video, Brachman goes into detail about her incredible discovery and what it might mean for the future of treating PTSD and depression. 


Sources: TEDNational Institute of Mental Health

About the Author
Applied Sport and Exercise Science
Abbie is an AFAA certified personal trainer and fitness instructor with an interest in all things health-science. She has recently graduated with her BS in Applied Sport and Exercise Science from Barry University in Miami. Next, she intends to earn an MPH with a focus in Epidemiology.
You May Also Like
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
APR 20, 2022
Immunology
Rare Soil Microbe Shows Promise as New Antibiotic
APR 20, 2022
Rare Soil Microbe Shows Promise as New Antibiotic
  Antibiotic resistance has increased the demand for new antibiotic treatments. Now, researchers have found that a ...
APR 28, 2022
Genetics & Genomics
A Genetic Cause of Lupus is Identified
APR 28, 2022
A Genetic Cause of Lupus is Identified
Lupus is an autoimmune disease that can impact anyone, but tends to affects women between the ages of 15 and 45. The dis ...
MAY 13, 2022
Health & Medicine
Increased Mental Health Risks Linked to High Potency Cannabis Concentrates
MAY 13, 2022
Increased Mental Health Risks Linked to High Potency Cannabis Concentrates
As more states legalize cannabis for medical and recreational purposes, the association between excessive cannabis consu ...
JUN 06, 2022
Drug Discovery & Development
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
JUN 06, 2022
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
Weight loss achieved via bariatric surgery among adults with obesity is linked to a lower risk of developing cancer and ...
JUN 27, 2022
Plants & Animals
Developing a New Approach to Rabies Vaccination
JUN 27, 2022
Developing a New Approach to Rabies Vaccination
Rabies is a viral disease that can spread through the saliva. Several kinds of animals can get rabies, including humans ...
Loading Comments...